RWRalf Watzlawick

Ralf Watzlawick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ralf Watzlawick has a total of 185 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Minimally invasive tubular resection of spinal arachnoid webs

    by Florian Volz, Jürgen Beck, Ulrich Hubbe, Amir El Rahal, Christoph Scholz, Marc Hohenhaus, Ralf Watzlawick, Marco Bissolo, Lucas Becker, Marius Schwabenland, et al.

  • Strahlenbelastung in der Wirbelsäulenchirurgie

    by Jan-Helge Klingler, Ulrich Hubbe, Christoph Scholz, Florian Volz, Ralf Watzlawick, Jürgen Beck, Marc Hohenhaus

    Zusammenfassung: Die zunehmende Anwendung intraoperativer Bildgebung in der Wirbelsäulenchirurgie macht ein fundiertes Verständnis von Dosisbegriffen und Strahlenschutzmaßnahmen erforderlich. Diese Übersichtsarbeit vermittelt praxisrelevantes Wissen zur Strahlenbelastung bei spinalen Eingriffen durch systematische Darstellung der physikalischen Grundlagen ionisierender Strahlung und Analyse aktueller Literatur zu verschiedenen OP-Verfahren. Die natürliche Strahlenexposition beträgt in Deutschland durchschnittlich 2,1 mSv/Jahr, medizinische Anwendungen tragen weitere 1,7 mSv/Jahr bei. Die Strahlenexposition variiert bei wirbelsäulenchirurgischen Eingriffen erheblich: Bei der lumbalen Diskektomie reichen publizierte Durchleuchtungszeiten von 4,6 bis zu 34,9 Sekunden. Ohne konsequenten Strahlenschutz können Operateure bei Vertebroplastien bereits nach 61 Eingriffen die jährlichen Grenzwerte überschreiten, mit optimierten Protokollen ist eine Erhöhung auf 646 Kyphoplastien möglich. Durch Kombination technischer Maßnahmen (ALARA-Prinzip, optimierte Geräteeinstellungen), organisatorischer Aspekte (Schulungen, Protokolle) und persönlicher Schutzausrüstung lässt sich die Strahlenbelastung für Patienten und OP-Team erheblich reduzieren. Die Integration von 3D-Navigation und robotisch-assistierten Verfahren bietet zusätzliche Möglichkeiten zur Dosisminimierung für das OP-Team bei gleichzeitiger Verbesserung der Behandlungsqualität.

  • Open Access

    Cerebral amyloid angiopathy in spontaneous intracerebral hemorrhage – radiology and immunohistochemistry in a consecutive surgical series

    by Ralf Watzlawick, Roland Roelz, Leon-Shanun Schroth, Ahmed Elbaz, Marc Hohenhaus, Mateo Tomas Fariña Nuñez, Jakob Straehle, Samer Elsheikh, Marco Prinz, David Seiffge, et al.


  • Open Access

    Twist-Drill Craniostomy With Pressure-Controlled Fibrinolytic Irrigation Therapy for the Evacuation of Acute Traumatic Subdural Hematoma in Patients Not Requiring Immediate Craniotomy

    by Marco Bissolo, Roberto Doria-Medina, Theresa Bettina Loidl, István Csók, Mukesch Johannes Shah, Eva Rohr, Klaus-Jürgen Buttler, Ralf Watzlawick, Christoph Scholz, Jürgen Beck, et al.

    BACKGROUND AND OBJECTIVES: Acute subdural hematoma (aSDH) ranks among the most prevalent conditions in neurosurgery. Depending on the hematoma and neurological condition, management is surgical or conservative. Open craniotomy is the mainstay of therapy if evacuation is mandated but is associated with considerable risks. We present a novel minimally invasive approach—twist-drill craniostomy with pressure-controlled subdural fibrinolytic irrigation (TDC-FIT)—for safe and efficient removal of aSDH in patients not requiring immediate evacuation and evaluate the outcome. METHODS: From June to December 2023, 10 patients with aSDH, Glasgow Coma Scale ≥13, hematoma thickness ≥7 mm, moderate neurological deficits without symptom progression, and no need for immediate evacuation were treated with TDC-FIT. A catheter with pressure-controlled irrigation containing an electrolyte solution with 200 000 IU/L urokinase at a target rate of 100 mL/h was inserted into the aSDH through a 3.5 mm TDC under local anesthesia. Irrigation was performed until radiological clearance of the aSDH was obtained. Outcome was compared with 30 historical matched controls treated with open craniotomy (Craniotomy cohort). RESULTS: In the TDC-FIT cohort, a near-complete hematoma resolution was observed in 9 (90%) patients, with 1 later recurrence of a chronic SDH, which subsequently resolved without additional sequelae after a conventional TDC. A total of 9 (90%) patients achieved independence (modified Rankin Scale 0-3) at 3 months, compared with 17 (56.7%) in the Craniotomy cohort (P = .012). One (10%) patient necessitated an open craniotomy because of neurological deterioration. The Craniotomy cohort experienced perioperative complications in 17 (56.7%) cases. Aphasia occurred in 2 (6.7%), hemiparesis in 4 (13.3%), epilepsy in 8 (26.6%), rehemorrhage in 2 (6.7%), meningitis in 1 (3.3%), and death in 2 (6.7%) patients. CONCLUSION: TDC-FIT on aSDH may offer a safe and effective alternative to open surgery in patients not requiring immediate evacuation.


  • Open Access

    A simple CT score predicts early neurological disability and survival in supratentorial intracerebral hemorrhage - The intracerebral mass and brain edema score (IMBES)

    by Ralf Watzlawick, Panagiotis Fistouris, Ahmed Elbaz, Pierre Scheffler, Alix Bührle, Marc Hohenhaus, Ramy Amirah, Roland Roelz, Mukesch Shah, Oliver Schnell, et al.


  • Targeting Nerve Fiber Outgrowth Inhibition After Experimental Spinal Cord Injury: A Systematic Review and Meta-analysis of Chondroitinase ABC

    by Alireza Khanteymoori, Clayton Peterson, Roza Atamny, Marc Hohenhaus, Jürgen Beck, David W. Howells, Jan M. Schwab, Ralf Watzlawick

    Background: Spinal cord injury (SCI) can impair motor, sensory, and autonomic function. The formation of the glial scar comprises protective as well as inhibitory neurite outgrowth properties operated by the deposition of chondroitin sulfate proteoglycans (CSPG). Chondroitinase ABC (ChABC) can degrade CSPG and foster neuroaxonal plasticity as a therapeutic approach to restore locomotor function after SCI. Objectives: To systematically review experimental ChABC treatments after SCI and assess their efficacy for locomotor function a comprehensive literature search was conducted following pre-registered Prospero Study protocol, selecting animal studies evaluating neurobehavioral outcomes after traumatic SCI followed by the calculation of normalized effect sizes applying meta-analysis and meta-regression methodology. Additional analyses were performed to investigate the impact of animal type, strain, sex, sample size, injury models, level of injury, and treatment duration. Results: Within the overall analysis of 1066 animals, a considerable amount of heterogeneity was observed. A subgroup analysis comprising experiments applying the same neurobehavioral measurement (blood–brain barrier/Basso-Mouse-Scale [BMS]-subgroup) demonstrated a 15.9% (95% CI = 11.3%-20.6%) improvement in locomotor outcomes. Different experimental characteristics influenced neurological recovery, including sex, level of injury, used anesthetic, reported dosage of ChABC treatment, the timepoint of assessment and perioperative temperature control. Sensitivity analysis applying Trim and Fill identified 19 hypothetical missing experiments suggestive of reporting bias. Conclusion: Reporting bias in experimental SCI research is prevalent and not limited to a specific intervention. ChABC treatment can exert beneficial effects on locomotor recovery after SCI.


  • Open Access

    Effect-Size Discrepancies in Literature Versus Raw Datasets from Experimental Spinal Cord Injury Studies: A CLIMBER Meta-Analysis

    by Emma G. Iorio, Alireza Khanteymoori, Kenneth A. Fond, Anastasia V. Keller, Lex Maliga Davis, Jan M. Schwab, Adam R. Ferguson, Abel Torres-Espin, Ralf Watzlawick

    Translation of spinal cord injury (SCI) therapeutics from pre-clinical animal studies into human studies is challenged by effect size variability, irreproducibility, and misalignment of evidence used by pre-clinical versus clinical literature. Clinical literature values reproducibility, with the highest grade evidence (class 1) consisting of meta-analysis demonstrating large therapeutic efficacy replicating across multiple studies. Conversely, pre-clinical literature values novelty over replication and lacks rigorous meta-analyses to assess reproducibility of effect sizes across multiple articles. Here, we applied modified clinical meta-analysis methods to pre-clinical studies, comparing effect sizes extracted from published literature to raw data on individual animals from these same studies. Literature-extracted data (LED) from numerical and graphical outcomes reported in publications were compared with individual animal data (IAD) deposited in a federally supported repository of SCI data. The animal groups from the IAD were matched with the same cohorts in the LED for a direct comparison. We applied random-effects meta-analysis to evaluate predictors of neuroconversion in LED versus IAD. We included publications with common injury models (contusive injuries) and standardized end-points (open field assessments). The extraction of data from 25 published articles yielded n = 1841 subjects, whereas IAD from these same articles included n = 2441 subjects. We observed differences in the number of experimental groups and animals per group, insufficient reporting of dropout animals, and missing information on experimental details. Meta-analysis revealed differences in effect sizes across LED versus IAD stratifications, for instance, severe injuries had the largest effect size in LED (standardized mean difference [SMD = 4.92]), but mild injuries had the largest effect size in IAD (SMD = 6.06). Publications with smaller sample sizes yielded larger effect sizes, while studies with larger sample sizes had smaller effects. The results demonstrate the feasibility of combining IAD analysis with traditional LED meta-analysis to assess effect size reproducibility in SCI.

  • Open Access

    Inhibition of the Nogo-pathway in experimental spinal cord injury: a meta-analysis of 76 experimental treatments

    by Julian Hirt, Alireza Khanteymoori, Marc Hohenhaus, Marcel A. Kopp, David W. Howells, Jan M. Schwab, Ralf Watzlawick

    Recovery after spinal cord injury (SCI) may be propagated by plasticity-enhancing treatments. The myelin-associated nerve outgrowth inhibitor Nogo-A (Reticulon 4, RTN4) pathway has been shown to restrict neuroaxonal plasticity in experimental SCI models. Early randomized controlled trials are underway to investigate the effect of Nogo-A/Nogo-Receptor (NgR1) pathway blockers. This systematic review and meta-analysis of therapeutic approaches blocking the Nogo-A pathway interrogated the efficacy of functional locomotor recovery after experimental SCI according to a pre-registered study protocol. A total of 51 manuscripts reporting 76 experiments in 1572 animals were identified for meta-analysis. Overall, a neurobehavioral improvement by 18.9% (95% CI 14.5–23.2) was observed. Subgroup analysis (40 experiments, N = 890) revealed SCI-modelling factors associated with outcome variability. Lack of reported randomization and smaller group sizes were associated with larger effect sizes. Delayed treatment start was associated with lower effect sizes. Trim and Fill assessment as well as Egger regression suggested the presence of publication bias. Factoring in theoretically missing studies resulted in a reduced effect size [8.8% (95% CI 2.6–14.9)]. The available data indicates that inhibition of the Nogo-A/NgR1pathway alters functional recovery after SCI in animal studies although substantial differences appear for the applied injury mechanisms and other study details. Mirroring other SCI interventions assessed earlier we identify similar factors associated with outcome heterogeneity.


  • Open Access

    Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature

    by Alba Guijarro-Belmar, Anna Varone, Martin Rugema Baltzer, Saurav Kataria, Ezgi Tanriver-Ayder, Ralf Watzlawick, Emily Sena, Catriona J. Cunningham, Ann M. Rajnicek, Malcolm Macleod, et al.

    Study design: Systematic review and meta-analysis of preclinical literature. Objectives: To assess the effects of biomaterial-based combination (BMC) strategies for the treatment of Spinal Cord Injury (SCI), the effects of individual biomaterials in the context of BMC strategies, and the factors influencing their efficacy. To assess the effects of different preclinical testing paradigms in BMC strategies. Methods: We performed a systematic literature search of Embase, Web of Science and PubMed. All controlled preclinical studies describing an in vivo or in vitro model of SCI that tested a biomaterial in combination with at least one other regenerative strategy (cells, drugs, or both) were included. Two review authors conducted the study selection independently, extracted study characteristics independently and assessed study quality using a modified CAMARADES checklist. Effect size measures were combined using random-effects models and heterogeneity was explored using meta-regression with tau2, I2 and R2 statistics. We tested for small-study effects using funnel plot–based methods. Results: 134 publications were included, testing over 100 different BMC strategies. Overall, treatment with BMC therapies improved locomotor recovery by 25.3% (95% CI, 20.3–30.3; n = 102) and in vivo axonal regeneration by 1.6 SD (95% CI 1.2–2 SD; n = 117) in comparison with injury only controls. Conclusion: BMC strategies improve locomotor outcomes after experimental SCI. Our comprehensive study highlights gaps in current knowledge and provides a foundation for the design of future experiments.


  • Open Access

    Outcome heterogeneity and bias in acute experimental spinal cord injury

    by Ralf Watzlawick, Ana Antonic, Emily S. Sena, Marcel A. Kopp, Julian Rind, Ulrich Dirnagl, Malcolm Macleod, David W. Howells, Jan M. Schwab

    Objective To determine whether and to what degree bias and underestimated variability undermine the predictive value of preclinical research for clinical translation. Methods We investigated experimental spinal cord injury (SCI) studies for outcome heterogeneity and the impact of bias. Data from 549 preclinical SCI studies including 9,535 animals were analyzed with meta-regression to assess the effect of various study characteristics and the quality of neurologic recovery. Results Overall, the included interventions reported a neurobehavioral outcome improvement of 26.3% (95% confidence interval 24.3–28.4). Response to treatment was dependent on experimental modeling paradigms (neurobehavioral score, site of injury, and animal species). Applying multiple outcome measures was consistently associated with smaller effect sizes compared with studies applying only 1 outcome measure. More than half of the studies (51.2%) did not report blinded assessment, constituting a likely source of evaluation bias, with an overstated effect size of 7.2%. Assessment of publication bias, which extrapolates to identify likely missing data, suggested that between 2% and 41% of experiments remain unpublished. Inclusion of these theoretical missing studies suggested an overestimation of efficacy, reducing the effect sizes by between 0.9% and 14.3%. Conclusions We provide empirical evidence of prevalent bias in the design and reporting of experimental SCI studies, resulting in overestimation of the effectiveness. Bias compromises the internal validity and jeopardizes the successful translation of SCI therapies from the bench to bedside.